CHI3L1 and myeloid sarcoma: Also, Burman and colleagues in 2016 suggested that increased levels of CSF CHI3L1 are associated with tissue damage related to inflammation and might predict residual disabilities and possibly cumulative damage over time, which were found more in progressive MS patients than RRMS, so high levels of CHI3L1 were associated with higher EDSS scores [33].